Checkpoint Inhibitor-induced Liver Injury

计划入组 160 人 · 首次发布于 2020 年 7 月 20 日

Personalizing Immune Checkpoint Inhibitor Therapy

首次发布于 2018 年 1 月 24 日

SNUH Immune Checkpoint Inhibitor-induced Hypothyroidism Recovery Trial

计划入组 107 人 · 首次发布于 2026 年 2 月 19 日

14-25-9

SN-PD07

GSK-5628

BCN Checkpoint

Checkpoint Therapeutics

United States

ImmunoBrain Checkpoint Ltd.

Israel

Neoadjuvant Immune Checkpoint Inhibitors Improve Outcomes in Early Breast Cancer

Checkpoint Inhibitor Use Surges Following FDA Approval for Gastroesophageal Cancer Treatment

Zynyz Plus Chemotherapy Shows Promise in Advanced Anal Cancer